We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
This article is cited by
-
Allogeneic hematopoietic cell transplant for normal karyotype AML: indirect evidence of selection for adverse molecular profile
Bone Marrow Transplantation (2015)
-
Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome
Annals of Hematology (2015)
-
Allo-SCT using BU, CY and melphalan for children with AML in second CR
Bone Marrow Transplantation (2013)
-
Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation
Bone Marrow Transplantation (2012)
-
Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia
Annals of Hematology (2012)